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Abstract: Black sesame seed is a potential herbal medicine for osteoarthritis treatment as it contains sesamin, which has antiinflammatory
properties and has demonstrated chondroprotective effects in many species. Horses are particularly susceptible to osteoarthritis.
Inflammatory mediators and matrix metalloproteinase are important factors causing cartilage degradation. This study aimed to
investigate the protective potential of sesamin (0.5–2.0 µM) against interleukin (IL)-1β-induced equine cartilage explant degradation.
The cartilage degradation was monitored by measuring the release of cartilage matrix molecules in culture media including sulfatedglycosaminoglycans and hyaluronan by calorimetric assay and ELISA assay, respectively. The remaining contents of collagen and uronic
acid (UA) within the explant tissue were assessed by hydroxyproline assay and UA assay, respectively. Cartilage-degrading enzymes
MMP-2 and MMP-3 were evaluated by gelatin zymography and ELISA assay, respectively. The results indicated that sesamin suppressed
IL-1β-induced equine cartilage degradation by reducing the levels of sulfated-glycosaminoglycans and hyaluronan, and preserving the
contents of UA and collagen within the explant tissues. The activity of MMP-2 and the quantity of MMP-3 were also suppressed by
sesamin. The chondroprotective efficacy of sesamin was comparable to that of diacerein, an antiarthritic drug. Lactate dehydrogenase
assay showed that sesamin at concentrations of up to 2 mM did not cause cytotoxicity to chondrocytes in cartilage explants. These results
may lead to new options for osteoarthritis treatment in horses.
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Joint diseases cause chronic health issues in athletic
animals, including horses. In Europe, more than 44.8%
of sport horses were retired and/or consequently
euthanized due to osteoarthritis [1]. Injury to joints and
surrounding tissues induces inflammatory processes.
Proinflammatory mediators, especially interleukin (IL)1β and proteolytic enzymes, are released into the synovial
fluid, causing articular cartilage destruction [2]. Matrix
metalloproteinases, including MMP-1 (collagenase 1),
MMP-2 (gelatinase), MMP-3 (stromelysin 1), MMP-9
(gelatinase), and MMP-13 (collagenase 3), play major
catalytic roles in the cartilage [3–9]. Osteoarthritis
treatments usually combine medicine, surgery, and physical
therapy. Alternative medicines such as acupuncture and
herbal medicine are introduced in some cases in order to
minimize the side effects of the main treatments and to
increase the quality of life of the patient.
Black sesame is known as an herb that can be used
as a health promotion supplement and as a medicine
for clinical conditions such as dermatitis, migraine, and
joint pain. Black sesame contains lignans such as sesamin

and sesamolin [10]. Previous studies demonstrated the
antiinflammatory effects of sesamin both in vivo [11–14]
and in vitro [15]. It has been reported that sesamin extract
reduced pathogenesis of arthritis by increasing articular
cartilage thickness in inflammation-induced mice.
Furthermore, the extract not only significantly reduced
cartilage degradation but also enhanced both collagen and
sulfated-glycosaminoglycan synthesis within the cartilage
tissue [16].
It was therefore of interest to determine whether
sesamin would have similar effects in horse cartilage. This
study aimed to investigate the chondroprotective effect of
sesamin on equine articular cartilage degradation induced
by IL-1β in a cartilage explant model.
Equine articular cartilage samples were obtained within
6 h post mortem from an equine patient after consent was
obtained from the owner. The animal had no clinical signs
of joint disease. The articular cartilage was collected from
the stifle joints of both hindlimbs. Full thickness cartilage
biopsies were harvested aseptically and trimmed into
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cartilage explants of approximately 3 × 3 mm2. The explants
were then transported to the laboratory in Dulbecco’s
modified Eagle medium (DMEM; GIBCO) with 200 U/
mL penicillin G sodium and 200 unit/mL streptomycin.
The explants were rinsed at least three times with the
same medium before being weighed and cultured in 12well tissue culture plates containing 0.5 mL of serum-free
DMEM with 200 U/mL penicillin G sodium and 200 U/mL
streptomycin in each well. The cultures were maintained
at 37 °C under 5% CO2. The tissue culture media in the
first 24 h were collected as day 0 samples. The media were
replaced weekly, and the explants were cultured for 7 or 21
days with various treatments. Untreated control explants
were cultured in media without any additional substances.
The IL-1β group was treated with 10 ng/mL recombinant
human IL-1β (Sigma-Aldrich). The sesamin groups

received a co-treatment of 10 ng/mL recombinant human
IL-1β in addition to 0.5, 1.0, or 2.0 µM sesamin (SigmaAldrich). Diacerein (TRB Chemidica), an antiarthritic
drug, at a concentration of 20 µM was treated in parallel
as the positive control. Collected tissues and culture media
were kept at –20 °C until use.
Cartilage biomolecules that were released into the tissue
culture media were evaluated. Sulfated-glycosaminoglycans
were measured by a colorimetric dye binding assay [17].
Hyaluronan was measured by competitive inhibitionbased ELISA [18]. IL-1β successfully induced significant
release of sulfated-glycosaminoglycans and hyaluronan
compared to the control. Sesamin at a concentration of
2 µM significantly suppressed the release of sulfatedglycosaminoglycans and hyaluronan induced by IL-1β,
comparable to the diacerein group (Figure 1). In addition

Figure 1. Sulfated-glycosaminoglycans (S-GAGS) (A) and hyaluronan (HA) (B) release percentages relative to the control groups.
Comparison among the IL-1β group (10 ng/mL IL-1β), the diacerein group (20 µM diacerein), and the sesamin groups (0.5, 1.0, and
2.0 µM sesamin) on day 7 of the cartilage explant cultures. Data were analyzed using STATA version 9.2 with 95% confidence intervals
(P < 0.05). The percentage concentration of sulfated-glycosaminoglycans and hyaluronan between the control and IL-1β group were
compared by unpaired t-test, while the IL-1β group and the other treatment groups were compared by ANOVA.
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to the detection of catabolic markers that were released
into the tissue culture media, the remaining collagen and
uronic acid (UA) contents within the explants were also
analyzed on day 21 using a hydroxyproline assay [19]
and a UA assay [18], respectively. The results showed an
obvious but not statistically significant reduction of UA
and collagen contents after IL-1β induction. Although
there was no statistically significance, sesamin and
diacerein showed the increasing trend of UA and collagen
contents in the explants compared to the cytokine-treated
group (Figures 2). These findings suggest that sesamin
protects against IL-1β-induced release of cartilage matrix
molecules similarly to diacerein, the standard antiarthritic
drug.
Matrix metalloproteinase-2 (MMP-2) activity was
measured by gelatin zymography [20], and the MMP3 level was analyzed using a human MMP-3 test kit
(Elabscience). The results from the gelatinolytic assay
showed that tissue culture media of IL-1β-induced
explants had higher MMP-2 activity. This activity increase
was reduced by co-treatment with diacerein or 2 µM

sesamin (Figure 3A). The MMP-3 level was increased
after treatment with the proinflammatory cytokine IL-1β,
but tended to be decreased with additional sesamin and
diacerein (Figure 3B). However, these changes were not
statistically significant. These results suggest that sesamin
may attenuate the effects of IL-1β on activation of the
production of MMPs, leading to the slowing of cartilage
matrix degradation in the equine model comparably
to diacerein, an IL-1β inhibitor [21–23], in our equine
cartilage study.
Sesamin toxicity on cartilage explant cultures was tested
by detecting lactate dehydrogenase (LDH), which indicates
the death of cells [24], including chondrocytes. H2O2 at a
concentration of 10 mM was used as the positive control.
After culturing for 7 days, sesamin at concentrations of
0.5 to 2 µM did not alter LDH levels compared to the
control group, while the explants that were treated with
hydrogen peroxide showed highly significant increases in
LDH. However, sesamin at 4 µM significantly increased
LDH (Figure 4). Therefore, only 0.5 to 2 µM sesamin was
applied in the experiments.

Figure 2. Percentage relative to the control group of UA (A) and collagen (B) content within the cartilage explants on day 21 of the
cartilage explant cultures. Comparison among the IL-1β group (10 ng/mL IL-1β), the diacerein group (20 µM diacerein), and the
sesamin groups (0.5, 1.0, and 2.0 µM sesamin). Data were analyzed using STATA version 9.2 with 95% confidence intervals (P < 0.05).
The percentage concentrations of UA and collagen between the control and IL-1β group were compared by unpaired t-test, while the
IL-1β group and the other treatment groups were compared by ANOVA.
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Figure 3. (A) Gelatin zymography of the activity of MMP-2 in the tissue culture media
compared with the control group, the IL-1β group (10 ng/mL IL-1β), the diacerein
group (20 µM diacerein), and the sesamin groups (0.5, 1.0, and 2.0 µM sesamin). Band
densities were determined using TotalLab TL120 v2009 software and are represented
as density fold compared to the control. (B) Percentage relative to the control of
MMP-3 released into the tissue culture media. Comparison among the IL-1β group
(10 ng/mL IL-1β), the diacerein group (20 µM diacerein), and the sesamin groups
(0.5, 1.0, and 2.0 µM sesamin). The MMP-2 zymography result was not statistically
tested. The percentage concentrations of MMP-3 between the control and IL-1β group
were compared by unpaired t-test, while the IL-1β group and the other treatment
groups were compared by ANOVA.

Figure 4. Lactate dehydrogenase (LDH) percentage relative to the control group.
Comparison among treated group (10 mM H2O2), IL-1β group (10 ng/mL IL-1β), the
diacerein group (20 µM diacerein), and the sesamin groups (0.5, 1.0, 2.0, and 4.0 µM
sesamin). Data were analyzed using STATA version 9.2 with 95% confidence intervals
(P < 0.05). The percentages of LDH between the control and IL-1β group were
compared by unpaired t-test, while the IL-1β group and the other treatment groups
were compared by ANOVA.
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Taken all together, our results demonstrated the
chondroprotective potential of sesamin in equine cartilage
explant degradation induced by IL-1β, one of the key
proinflammatory cytokines that involves pathogenesis of
osteoarthritis. Accordingly, sesamin may be applied as
an alternative treatment for osteoarthritis in human and
animals, including horses.
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